Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 to 75 years, either male or female.
- People with a laboratory-confirmed diagnosis of non-small cell lung cancer (NSCLC), including types such as adenocarcinoma, squamous cell carcinoma, or other NSCLC subtypes.
- People whose cancer was assessed as stage IIIA or IIIB at the time of first diagnosis, and whose medical team determined that pre-surgery treatment with chemotherapy and immunotherapy followed by surgery was appropriate.
- People who have already completed 2 to 4 rounds of pre-surgery treatment using a platinum-based chemotherapy combination together with a PD-1 inhibitor (a type of immunotherapy).
- People who have undergone a specific type of lung surgery that completely removed the tumour, including removal of a lobe or the whole lung along with nearby lymph nodes, with no cancer left at the edges of the removed tissue.
- People whose post-surgery pathology results show that cancer was still found in lymph nodes in the chest, even though the main tumour was fully removed.
- People with a general health and activity level rated as 0 or 1 on a standard medical scale, meaning they are either fully active or have only minor limitations on strenuous activity (confirm with trial site).
- People whose blood counts and kidney and liver function meet the levels required by the trial protocol (confirm with trial site for specific values).
- People who are able to begin post-surgery radiation therapy and/or ongoing immunotherapy between 4 and 10 weeks after surgery, or after recovering from any post-surgery complications.
- People who have read and signed a consent form agreeing to take part in the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose surgery did not fully remove the cancer, meaning cancer cells were found at or near the edges of the removed tissue.
- People who have previously had radiation therapy to the chest area that would overlap with the treatment area planned in this trial.
- People who currently have an active infection that is not under control, or who have ongoing immune-related side effects from prior immunotherapy that are rated at a moderate level or above and have not resolved.
- People with a history of serious autoimmune disease that has required ongoing treatment with medications that suppress the immune system.
- People with uncontrolled lung disease involving scarring or inflammation of lung tissue.
- People who have cancer that has spread to the brain or nervous system, where symptoms are present or where the spread has not yet been treated.
- People with any other condition that the trial doctor believes could put the person at risk or prevent them from safely following the trial requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Disease-Free Survival (DFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.